Table 1.
Synthetic genetic interaction described in this study
| Genotype | Phenotype | Source |
|---|---|---|
| swi1Δ ctf18Δ | Lethal | This study |
| swi3Δ ctf18Δ | Lethal | This study |
| swi1Δ chl1Δ | No apparent phenotypic enhancement | This study |
| swi3Δ chl1Δ | No apparent phenotypic enhancement | This study |
| chl1Δ ctf18Δ | Lethal | This study |
| swi1Δ rad21-K1 | Lethal | This study |
| ctf18Δ rad21-K1 | Phenotypic enhancement | This study |
| chl1Δ rad21-K1 | Phenotypic enhancement | This study |
| swi1Δ rqh1Δ | Severe growth defect | Noguchi et al. (2003) |
| swi3Δ rqh1Δ | Lethal | This study |
| ctf18Δ rqh1Δ | Phenotypic enhancement | This study |
| ctf18Δ cds1Δ | No apparent increase in UV and HU sensitivity | This study |
| Phenotypic enhancement in MMS and CPT sensitivity | This study | |
| ctf18Δ chk1Δ | Phenotypic enhancement in UV and HU sensitivity | This study |
| Phenotypic enhancement in MMS and CPT sensitivity | This study | |
| ctf18Δ rad3Δ | No apparent increase in UV and HU sensitivity | This study |
| Phenotypic enhancement in MMS and CPT sensitivity | This study | |
| chl1Δ cds1Δ | No apparent increase in MMS, CPT, and TBZ sensitivity | This study |
| chl1Δ chk1Δ | Phenotypic enhancement in MMS and CPT sensitivity | This study |
| chl1Δ rad3Δ | Phenotypic enhancement in MMS, CPT, and TBZ sensitivity | This study |